We present a case of 26 years multigravid women (G2PoLoA1) with iso-immunized foetus with high titre 1:512, delivered at 36+6 weeks of pregnancy. She visited the hospital in the second trimester of pregnancy for routine antenatal check up. There was a past history of spontaneous abortion at 12 weeks where no immunoglobulin (rhogam) injection was taken. At 22+ weeks of gestation, she was admitted in the hospital with titre 1:128 and 1:512. Counseling was done for outcome of foetus and advised for termination, but parents wanted to continue the pregnancy. Dexamethasone injection was given for foetal lung maturity and then discharged. Baby was kept in the nursery and double phototherapy was given and discharged at the seventh day of life.
Aims: The aim was to analyze patient’s age, gestational age, mode of delivery, types of complication, fetomaternal outcome and prognosis in eclampsia. Methods: This was a retrospective one year study done at Nepalgunj medical college from June 2009 to May 2010. Results: Out of 21 (1.11%) eclampsia, nine (42.85%) were <20 years, nine (42.85%) were at term and 15 (71.43%) were primi para. Systolic blood pressure recorded >160 mm Hg in eight (38.10%) and diastolic blood pressure recorded 91-100 mm Hg were nine (42.8%). Antepartum and intrapartum eclampsia were 18 (85.72%) and two (9.52%) respectively. Nine (42.86%) had lower segment cesarean section. Ten (47.62%) babies were alive. All the patients were treated with magnesium sulphate and survived. Conclusions: Most of the patients in this study were primi para at term pregnancy. Patients were treated with magnesium sulphate that prevented maternal mortality. DOI: http://dx.doi.org/10.3126/njog.v9i1.11195 NJOG 2014 Jan-Jun; 2(1):74-77
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.